Vectors for Molecule Delivery to CD11b Expressing Cells

Details for Australian Patent Application No. 2007203473 (hide)

Owner Institut Pasteur Centre National De La Recherche Scientifique

Inventors Guiso, Nicole; Guermonprez, Pierre; Fayolle, Catherine; Ladant, Daniel; Khelef, Nadia; Mohammed, El-Azami El-Idrissi; Leclerc, Claude; Bauche, Cecile

Agent Cullens

Pub. Number AU-B-2007203473

Parent 2001293855

Filing date 25 July 2007

Wipo publication date 16 August 2007

Acceptance publication date 14 April 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/13 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

Event Publications

9 August 2007 Complete Application Filed

16 August 2007 Application Open to Public Inspection

  Published as AU-B-2007203473

14 April 2011 Application Accepted

  Published as AU-B-2007203473

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

15 September 2011 Section 223 Application Allowed

  Centre National De La Recherche Scientifique; Institut Pasteur The time in which to pay the acceptance fee has been extended to 14 Sep 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2008

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007203474-Improvements in Floor Waste Arrangements

2007203472-Tissue implant for cartilage repair